Author

Behzad Mesbahzadeh

Observed names: B Mesbahzadeh, Behzad  Mesbahzadeh, Mesbahzadeh, Behzad
ORCID: 0000-0003-0695-5978
Observed ORCID: 0000-0003-0695-5978
OpenAlex ID: A5050707407
2021 · Behzad Mesbahzadeh, Mohammadmehdi Hassanzadeh-Taheri, et al. · BMC Urology · 53
2006 · B Mesbahzadeh, Z Ghiravani, et al. · PubMed · 24
2014 · Zoya Tahergorabi, Moudi Mitra, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 16
2021 · Behzad Mesbahzadeh, Hossein Salarjavan, et al. · Current Molecular Pharmacology · 7
2024 · Seyed Hadi Hosseini, Maryam Nazarian, et al. · Cardiovascular Toxicology · 6
2019 · Behzad Mesbahzadeh, Nasroallah Moradi-kor, et al. · BioMolecular Concepts · 5
2018 · Raheleh Hashemi Habybabady, Seyed Bagher Mortazavi, et al. · Malaysian Journal of Medical Sciences · 5
2023 · Nahid Ghanbarzadeh, Pouria Mohammadparast-Tabas, et al. · Journal of Reproduction & Infertility · 3
2015 · Mahmoodreza Behravan, Mohammad Malekaneh, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 3
2023 · Behzad Mesbahzadeh, Abolfazl Hatami-moghaddam, et al. · Current Drug Discovery Technologies · 2
2021 · Behzad  Mesbahzadeh, Mohammad Reza Ameli, et al. · Modern Care Journal · 2
2015 · Anani Sarab Gholamreza, Asadi Fard Masoomeh, et al. · 2
2025 · Behzad Mesbahzadeh, Negar Moodi, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1
2016 · Behzad Mesbahzadeh, Azadeh Shahroodi, et al. · 1
2026 · Amirhossein Rakhshanifard, Saeed Samarghandian, et al. · Central Nervous System Agents in Medicinal Chemistry
2025 · Tahereh Farkhondeh, Fatemeh Ahrari, et al. · Endocrine Metabolic & Immune Disorders - Drug Targets
Works count: 31
Citation count: 199
H-index: 7
I10-index: 6
Year
Topic
Type